{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:13:53Z","timestamp":1758820433486},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s11864-003-0013-z","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:41:17Z","timestamp":1183020077000},"page":"121-130","source":"Crossref","is-referenced-by-count":9,"title":["Endometrial cancer: Treatment of nodal metastases"],"prefix":"10.1007","volume":"4","author":[{"given":"D. Scott","family":"McMeekin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Tillmanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15:10\u201317.","journal-title":"Gynecol Oncol"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","volume":"60","author":"WT Creasman","year":"1987","unstructured":"Creasman WT, Morrow CP, Bundy BN, et al.: Surgical pathologic spread patterns of endometrial cancer. Cancer 1987, 60:2035\u20132041. A landmark study describing the distribution of disease spread in patients with endometrial cancer who are surgically staged. Data from this 1987 study continue to guide most decisions in the management of endometrial cancer.","journal-title":"Cancer"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","volume":"40","author":"CP Morrow","year":"1991","unstructured":"Morrow CP, Bundy BN, Kurman RJ, et al.: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991, 40:55\u201365. The companion study to Creasman et al. [2]. It reports how patterns of disease spread are correlated with outcome.","journal-title":"Gynecol Oncol"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/gyno.2001.6157","volume":"81","author":"DS McMeekin","year":"2001","unstructured":"McMeekin DS, Lashbrook D, Gold MA, et al.: Analysis of FIGO stage IIIC endometrial cancer patients. Gynecol Oncol 2001, 81:273\u2013278. The analysis is one of the largest series involving patients with stage IIIC endometrial cancer, and provides support for the importance for surgical therapy in this patient group.","journal-title":"Gynecol Oncol"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1006\/gyno.1999.5569","volume":"75","author":"G Nelson","year":"1999","unstructured":"Nelson G, Randall M, Sutton G, et al.: FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999, 75:211\u2013214.","journal-title":"Gynecol Oncol"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/gyno.1995.1208","volume":"58","author":"L Chuang","year":"1995","unstructured":"Chuang L, Burke TW, Tornos C, et al.: Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995, 58:189\u2013193.","journal-title":"Gynecol Oncol"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1006\/gyno.1999.5548","volume":"75","author":"RW Naumann","year":"1999","unstructured":"Naumann RW, Higgins RV, Hall JB: The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists. Gynecol Oncol 1999, 75:4\u20139.","journal-title":"Gynecol Oncol"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1006\/gyno.2001.6494","volume":"84","author":"JM Straughn","year":"2002","unstructured":"Straughn JM Jr, Huh WK, Kelly FJ, et al.: Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002, 84:191\u2013193.","journal-title":"Gynecol Oncol"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/gyno.1995.1005","volume":"56","author":"LC Kilgore","year":"1995","unstructured":"Kilgore LC, Partridge EE, Alvarez RD, et al.: Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995, 56:29\u201333.","journal-title":"Gynecol Oncol"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.1997.313","volume":"75","author":"T Onda","year":"1997","unstructured":"Onda T, Yoshikawa H, Mizutani K, et al.: Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy, and radiation therapy. Br J Cancer 1997, 75:1836\u20131841.","journal-title":"Br J Cancer"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1006\/gyno.1999.5688","volume":"76","author":"A Mariani","year":"2000","unstructured":"Mariani A, Webb MJ, Galli L, et al.: Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000, 76:348\u2013356.","journal-title":"Gynecol Oncol"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1006\/gyno.2001.6314","volume":"82","author":"D Scribner","year":"2001","unstructured":"Scribner D, Walker J, Johnson G, et al.: Laparoscopic pelvic and para-aortic lymph node dissection: analysis of the first 100 cases. Gynecol Oncol 2001, 82:498\u2013503. The analysis describes one of the largest series of laparoscopic nodal dissections.","journal-title":"Gynecol Oncol"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0360-3016(92)90675-8","volume":"24","author":"BW Corn","year":"1992","unstructured":"Corn BW, Lanciano RM, Greven KM, et al.: Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 1992, 24:223\u2013227.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR14","first-page":"821","volume":"20","author":"DS McMeekin","year":"2001","unstructured":"McMeekin DS, Garcia M, Gold MA, et al.: Stage IV endometrial cancer: survival, recurrence, and role of surgery [abstract]. Proc Am Soc Clin Oncol 2001, 20:821.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","volume":"36","author":"CP Morrow","year":"1990","unstructured":"Morrow CP, Bundy BN, Homesley HD, et al.: Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study. Gynecol Oncol 1990, 36:166\u2013171.","journal-title":"Gynecol Oncol"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9378(94)70340-X","volume":"170","author":"MR Smith","year":"1994","unstructured":"Smith MR, Peters WA III, Drescher CW: Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma. Am J Obstet Gynecol 1994, 170:1677\u20131682.","journal-title":"Am J Obstet Gynecol"},{"key":"13_CR17","first-page":"807","volume":"21","author":"GF Fleming","year":"2002","unstructured":"Fleming GF, Brunetto VL, Mundt AJ, et al.: Randomized trial of doxorubicin (DOX) plus cisplatin (CIS) versus DOX plus CIS plus paclitaxel (TAX) in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group (GOG) study [abstract]. Proc Am Soc Clin Oncol 2002, 21:807.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/gyno.1994.1245","volume":"55","author":"TW Burke","year":"1994","unstructured":"Burke TW, Gershenson DM, Morris M, et al.: Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol 1994, 55:47\u201350.","journal-title":"Gynecol Oncol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/gyno.2001.6321","volume":"83","author":"Y Aoki","year":"2001","unstructured":"Aoki Y, Kase H, Watanabe M, et al.: Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy. Gynecol Oncol 2001, 83:1\u20135.","journal-title":"Gynecol Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0013-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-003-0013-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0013-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0013-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T13:23:00Z","timestamp":1652620980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-003-0013-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11864-003-0013-z","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}